Immunocore Holdings (IMCR) FCF Margin Growth (1y) (2022 - 2026)

Immunocore Holdings (IMCR) FCF Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,187.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,525.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -341.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immunocore Holdings 1.80 Bn 957.43 Mn 106.24 Mn -1,473.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,473.00
Dec 31, 2025 -1,315.00
Sep 30, 2025 -3,031.00
Jun 30, 2025 -461.00
Mar 31, 2025 726.00
Dec 31, 2024 558.00
Sep 30, 2024 1,006.00
Mar 31, 2024 -2,091.00
Dec 31, 2023 -3,708.00
Sep 30, 2023 -346.00
Dec 31, 2022 45,041.00